Included in the formulation
АТХ:D.01.A.E.04 Undecylenic acid
Pharmacodynamics:
It has a fungistatic effect. Is active against dermatophytes: Epidermohpyton, Trichophyton and Microsporum.
Pharmacokinetics:Not studied.
Indications:Treatment and prevention of fungal diseases of the skin, mainly fungal lesions of the feet.
I.B35-B49.B35.4 Mycosis of the trunk
I.B35-B49.B35.3 Mycosis of the feet
I.B35-B49.B35.2 Mycosis brushes
I.B35-B49.B35.1 Mycosis of nails
I.B35-B49.B35.0 Mycosis of the beard and head
I.B35-B49 Mycosis
Contraindications:Hypersensitivity, age to 3 years.
Carefully:Children and the elderly, liver and kidney disease, pregnancy and lactation.
Pregnancy and lactation:The category of FDA recommendations is not defined.
Adequate and well-controlled studies in humans and animals have not been conducted. There is no information on the penetration into breast milk. Use with caution.
Dosing and Administration:Apply externally 2 times a day, the duration of treatment is usually 15-20 days or more, depending on the effectiveness and results of microscopic examination. At the end of the course of treatment, preventive use is recommended 1-2 times a week.
Side effects:Allergic reactions: rarely.
Interaction:Not described.
Special instructions:With extensive skin lesions,especially with acute dyshidrotic form or eczematous epidermophyte (to avoid exacerbation) to apply with caution.